DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
Meso-Erythritol is an investigational drug.
There have been 19 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2018.
The most common disease conditions in clinical trials are Mesothelioma, Neoplasms, Glandular and Epithelial, and Malaria. The leading clinical trial sponsors are Hrain Biotechnology Co.,Ltd., Stony Brook University, and Chinese University of Hong Kong.
There is one US patent protecting this investigational drug and nineteen international patents.
Recent Clinical Trials for Meso-Erythritol
|Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania||National Malaria Control Program, Tanzania||Phase 4|
|Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania||National Institute for Medical Research, Tanzania||Phase 4|
|BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma||Hoffmann-La Roche||Phase 3|
Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Meso-Erythritol||Start Trial||Aqueous foaming composition and method for homogenizingly incorporating water into lipophilic materials||Battelle Memorial Institute (Carouge, CH)||Start Trial|
|Meso-Erythritol||Start Trial||Silver halide color photographic material having improved dye image stability||Fuji Photo Film Co. Ltd. (Tokyo, JP)||Start Trial|
|Meso-Erythritol||Start Trial||Anti-clumping agents for expandable vinylaromatic-acrylonitrile polymeric materials||The Dow Chemical Company (Midland, MI)||Start Trial|
|Meso-Erythritol||Start Trial||Process for preparing partial polyol fatty acid esters||Van den Bergh Foods Co., Division of Conopco Inc. (New York, NY)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|